Company profile: Selkirk Pharma
1.1 - Company Overview
Company description
- Provider of aseptic fill/finish services for injectable drugs, including vaccines and biological therapeutics, as a contract manufacturing organization. Operates a purpose-built aseptic facility with unidirectional flow, single-use systems, SKAN isolator technology, and Bausch + Strobel VarioSys filling systems with integrated vial rinser and depyrogenation tunnel for efficient, high-yield manufacturing.
Products and services
- Aseptic Fill/Finish Services: Selkirk delivers advanced-technology-enabled aseptic filling and finishing for injectable drugs, including vaccines and biological therapeutics, maximizing product quality and yield
- Advanced Manufacturing Facility: A purpose-built, single-use-based aseptic facility equipped with unidirectional flow technology, SKAN isolator technology, and Bausch + Strobel VarioSys filling systems for parenteral manufacturing operations
- Bausch + Strobel VarioSys Fill Line: A high-yield VarioSys filler featuring an integrated vial rinser and depyrogenation tunnel, engineered for efficient drug product manufacturing within aseptic operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Selkirk Pharma
Inkemia
HQ: Spain
Website
- Description: Provider of high technological value knowledge generation, management and exploitation to support industries in the field of life sciences, focusing on creating and leveraging knowledge rather than being an industrial company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inkemia company profile →
Xcenda
HQ: United States
Website
- Description: Provider of strategic consultancy and managed markets agency services delivering strategic insights, health economics and outcomes research (HEOR) expertise, and reimbursement support to global companies and emerging pre-commercialization phase firms, with 20+ years of real-world experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcenda company profile →
McKesson
HQ: United States
Website
- Description: Provider of pharmaceutical distribution (branded, generic, OTC) to healthcare providers; wholesale medical supplies and equipment; pharmacy management tools and consulting; specialty practice solutions including value-based care, group purchasing, and EHR; biopharma commercialization, medication access and adherence programs; and biosimilars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full McKesson company profile →
Food and Drug Analytical Services
HQ: United Kingdom
Website
- Description: Provider of independent pharmaceutical quality control testing, delivering full contract testing services incorporating chemistry, microbiology, stability, and development capabilities to some of the UK's largest pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Food and Drug Analytical Services company profile →
AmbioPharm
HQ: United States
Website
- Description: Provider of peptide manufacturing and development services, including GMP and non-GMP custom peptide synthesis via solid phase, solution phase, or hybrid processes. Manufactures active pharmaceutical ingredients and generic peptides, develops research-grade complex peptides, and offers analytical development and validation for HPLC/UPLC, serving pre-clinical, medicinal, and toxicology programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AmbioPharm company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Selkirk Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Selkirk Pharma
2.2 - Growth funds investing in similar companies to Selkirk Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Selkirk Pharma
4.2 - Public trading comparable groups for Selkirk Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →